Mary Kathleen Reed, MD

NPI 1043393523ActiveIndividual· Internal Medicine, Hematology & Oncology· Flushing, NY

Internal Medicine, Hematology & Oncology (MD) in Flushing, New York, trained at Boston University School of Medicine (class of 1980). Part D covered 147 prescriptions written in 2024, 82% of them generic. Janssen Biotech, Inc. was the largest of 9 companies reporting payments in 2025, $402.65 in all, mostly food and beverage.

Overview

NPI	1043393523
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Oct 20, 2006
Last updated in NPPES	Jul 21, 2022

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Hematology & Oncology Primary	207RH0003X	153247	NY

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Hematology/Oncology (NY)

Part D prescriptions in 2024

Prescriptions (claims)	147 · 212 30-day fills
Patients	37
Total drug cost	$269,609
Generic share	82% of claims

Medicare sources and data years

Education and affiliations

Medical school	Boston University School of Medicine
Graduation year	1980
Medicare specialty	Hematology/Oncology
Secondary specialties	Hospice/Palliative Care, Internal Medicine